US markets are set for a higher open on ECB rate cut, upbeat earnings reports.
Phillip Frost backs SafeStitch and Warren Buffett holds DaVita.
Amgen, Celgene and Pharmacyclics see short interest drop recently.
There's mixed interest in biotech, biopharmaceutical and emerging pharma companies.
Novo Nordisk is downgraded to 'underweight,' and Verizon is upgraded to 'buy.'
Some major branded drugs will lose patent protection, and market share along with it, this year.
The pharmaceutical company's new CEO formerly worked for the Canadian company, long a rumored suitor.
VIDEO ON MSN MONEY
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.
MONEY & POLITICS
Breaking up big banks is an untested solution to the too big to fail problem that attempts to isolate and dismantle large, troubled institutions while protecting the rest of the economy.
Joe Cantrell says he faces charges after trying to take advantage of the retailer's policy.
The IRS is struggling to combat identify thieves who file fraudulent tax returns in the names of older residents who don't need to file.